Wemedoo joins Xraised again to share new perspectives

In the third Xraised episode, our Chief Product Officer, Dr.Nikola Cihoric discusses why clinical research is entering a crucial moment and how oomnia is built to support the next generation of trials.

2025 is shaping into a milestone year for Wemedoo, marked by winning the SCDM Innovator Start-up of the Year Award and partnering with Across Global Alliance, expanding access to 16 CROs in more than 60 countries.

Nikola explains that legacy platforms can no longer keep up with decentralized trials, multimodal data, and AI-driven workflows. Fragmented systems create delays, inconsistencies, and unnecessary operational burdens.

oomnia takes a different approach. Early results are already demonstrating significant impact:

• Trials launching 83% faster
• Complex studies live in 8 weeks instead of 6 months
• 66% fewer data queries
• Zero custom code needed to ensure system interoperability

These outcomes highlight how unification can change study timelines and simplify operations at scale.

Watch the full interview

Available on:
Spotify
Amazon